Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaojun Zhang

Showing results (71-80 of 207) with videos related to

Pageof 21
Sort By:
Physical Review. E|August 19, 2025
Maximum entropy models for patterns of gene expressionCamilla Sarra, Leopoldo Sarra, Luca Di Carlo, et al.
Journal of Oncology|October 23, 2019
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular CarcinomaFurong Liu, Minshan Chen, Jie Mei, et al.
The International Journal of Cardiovascular Imaging|June 23, 2017
A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine modelLi Shen, Yizhe Wu, Lei Ge, et al.
Cancer Management and Research|April 10, 2018
The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot studyYaojun Zhang, Junting Huang, Jinbin Chen, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2020
Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resectionZiming He, Jinbin Chen, Juncheng Wang, et al.
International Immunopharmacology|December 20, 2023
Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world studyZili Hu, Zhiwen Hu, Weixiang Zhan, et al.
Frontiers in Pharmacology|October 6, 2023
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombusZili Hu, Zhenyun Yang, Jiongliang Wang, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2012
Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapyYaojun Zhang, Adam E Frampton, Charis Kyriakides, et al.
Journal of Cancer|May 29, 2018
Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched AnalysisJinbin Chen, Shixun Lu, Yaojun Zhang, et al.
Journal of Hepatocellular Carcinoma|December 28, 2020
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?Xuqi Sun, Dandan Hu, Yaojun Zhang, et al.
Pageof 21

Showing results (71-80 of 207) with videos related to

Sort By:
Pageof 21
Physical Review. E|August 19, 2025
Maximum entropy models for patterns of gene expressionCamilla Sarra, Leopoldo Sarra, Luca Di Carlo, et al.
Journal of Oncology|October 23, 2019
Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Stage B1 Intermediate Hepatocellular CarcinomaFurong Liu, Minshan Chen, Jie Mei, et al.
The International Journal of Cardiovascular Imaging|June 23, 2017
A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine modelLi Shen, Yizhe Wu, Lei Ge, et al.
Cancer Management and Research|April 10, 2018
The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot studyYaojun Zhang, Junting Huang, Jinbin Chen, et al.
European Journal of Gastroenterology & Hepatology|February 13, 2020
Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resectionZiming He, Jinbin Chen, Juncheng Wang, et al.
International Immunopharmacology|December 20, 2023
Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world studyZili Hu, Zhiwen Hu, Weixiang Zhan, et al.
Frontiers in Pharmacology|October 6, 2023
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombusZili Hu, Zhenyun Yang, Jiongliang Wang, et al.
Journal of Cancer Research and Clinical Oncology|March 7, 2012
Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapyYaojun Zhang, Adam E Frampton, Charis Kyriakides, et al.
Journal of Cancer|May 29, 2018
Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched AnalysisJinbin Chen, Shixun Lu, Yaojun Zhang, et al.
Journal of Hepatocellular Carcinoma|December 28, 2020
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?Xuqi Sun, Dandan Hu, Yaojun Zhang, et al.
Pageof 21